Valuation: RaySearch Laboratories AB

Market Cap 5.81B 586M 514M 483M 442M 826M 56.12B 832M 2.25B 28.61B 2.2B 2.15B 92.77B P/E 2026 *
21.6x
P/E 2027 * 17.3x
Enterprise Value 5.96B 601M 528M 496M 454M 848M 57.62B 854M 2.31B 29.38B 2.26B 2.21B 95.24B EV / Sales 2026 *
4.27x
EV / Sales 2027 * 3.56x
Free-Float
80.09%
Yield 2026 *
2.32%
Yield 2027 * 2.76%
1 day-2.43%
1 week-4.65%
Current month-6.71%
1 month-7.12%
3 months-17.26%
6 months-7.93%
Current year-26.18%
1 week 167.7
Extreme 167.7
179.6
1 month 166.7
Extreme 166.7
191.2
Current year 153.1
Extreme 153.1
238.4
1 year 153.1
Extreme 153.1
264.5
3 years 78.8
Extreme 78.8
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
18/8/26 Sell

Chief Technology Officer

-3,203 0.0104%
17/8/26 Sell

Chief Technology Officer

-2,297 0.0075%
11/6/26 Buy

General Counsel

462 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-2.43%-4.65%-33.21%+107.27% 586M
+0.98%+3.36%-1.92%+33.67% 43.84B
+1.46%-0.99%-48.52%+128.37% 11.87B
+0.18%-7.10%-10.03%+109.11% 5.42B
+1.57%-2.64%+39.92% - 4.12B
-5.27%-6.60% - - 2.12B
-0.08%+0.63%+6.30%-32.32% 1.5B
+0.38%-1.58%-36.49% - 1B
+0.10%-4.24%+8.13%+155.53% 960M
-1.14%-5.35%+35.41%+42.69% 869M
Average -0.40%-1.14%-4.49%+77.76% 7.23B
Weighted average by Cap. +0.77%+0.48%-7.95%+58.28%

Financials

2026 *2027 *
Net sales 1.4B 141M 124M 116M 106M 199M 13.5B 200M 541M 6.88B 529M 518M 22.31B 1.63B 165M 144M 136M 124M 232M 15.77B 234M 632M 8.04B 618M 605M 26.07B
Net income 272M 27.45M 24.09M 22.65M 20.7M 38.69M 2.63B 38.98M 105M 1.34B 103M 101M 4.35B 338M 34.06M 29.89M 28.1M 25.69M 48M 3.26B 48.36M 131M 1.66B 128M 125M 5.39B
Net Debt 155M 15.64M 13.73M 12.9M 11.8M 22.05M 1.5B 22.21M 60.09M 764M 58.74M 57.45M 2.48B 7M 706K 620K 583K 533K 996K 67.66M 1M 2.71M 34.5M 2.65M 2.59M 112M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
25/09/26 SEK 168.30 -2.55% 89,473
23/09/26 SEK 172.70 +2.25% 120,515
22/09/26 SEK 168.90 -2.93% 132,142
21/09/26 SEK 174.00 -1.81% 267,120
18/09/26 SEK 177.20 +0.40% 64,539
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
172.70SEK
Average target price
297.50SEK
Spread / Average Target
+72.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RAY B Stock